MedTrace Logo

Transcorneal Electrical Stimulation - Multicenter Safety Study

NCT01835002 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 105

Last updated 2021-03-04

No results posted yet for this study

Summary

The purpose of this study is to expand the safety assessment of repeated applications of an electrical current from a DTL-like electrode in patients with RP.

Conditions

Interventions

DEVICE

Transcorneal electrostimulation

Weekly stimulation for 30 minutes with current of TES delivered of 150% of the individual phosphene threshold.

Sponsors & Collaborators

  • Okuvision GmbH

    lead INDUSTRY

Principal Investigators

  • Florian Gekeler, Prof Dr med · Eberhard-Karls-Universität Tübingen

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-09-30
Primary Completion
2014-07-31
Completion
2015-08-31

Countries

  • Denmark
  • Germany
  • Norway

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01835002 on ClinicalTrials.gov